Philip Morris International: World Health Organization Report on Tobacco Fails People Who Currently Smoke
The following is a statement from Philip Morris International.
On July 26, the World Health Organization released a report on global tobacco use which urges governments to step up efforts to help smokers quit. There is no question that the best choice is never to start using cigarettes or nicotine-containing products or if someone has, they should quit altogether. By encouraging governments to double down on efforts to help men and women who smoke quit, the WHO takes an admirable stance. But the reality is that even with the best treatments available today, many people will not succeed. In any given year, about nine out of 10 men and women who are already smoking will continue to do so; in turn, their risk of smoking-related disease will continue to increase. We, as a society, cannot turn our backs on those people.
Surprisingly, this report, funded by Bloomberg Philanthropies, fails to acknowledge the robust science and innovation behind alternatives to smoking cigarettes. The WHO misses a critical scientific point: It is the burning of tobacco that produces the vast majority of the harmful chemicals that cause smoking-related diseases, not tobacco itself. Hundreds of millions of men and women who don’t quit stand to gain the most from less harmful alternatives to cigarettes. In fact, a global survey of 31,000 people in 31 countries found that 88 percent of respondents think smokers should have access to less harmful alternatives to cigarettes. https://www.pmi.com/media-center/news/public-supports-alternatives-to-cigarettes. PMI’s alternatives alone have already helped 8 million people abandon cigarettes entirely.
“The WHO is failing the 1 billion men and women around the world that continue to smoke by continuing to ignore the science behind better alternatives to cigarettes,” said Dr. Moira Gilchrist, Vice President of Strategic and Scientific Communications, Philip Morris International. “There is no question that scientifically substantiated smoke-free alternatives are better than cigarettes. The WHO is perfectly situated to encourage independent research and provide science-based recommendations to smokers. Instead they seem to be closing down dialogue on promising alternatives to continued smoking, choosing instead to focus solely on pharmaceutical industry products.”
In 1997, the UN Focal Point on Tobacco or Health recommended that “in order to assist smokers who are so heavily dependent that they cannot possibly stop smoking, every effort should be made to reduce the toxicity of existing tobacco products.” The same report also recommends that “the WHO is requested to consider the above recommendations in future policy-development activities, including the drafting of a framework convention on tobacco control.”
PMI heeded the call for reduced toxicity products and for more than 20 years has been working on developing and scientifically assessing less harmful alternatives to cigarettes that do not create smoke, because they do not combust. PMI’s scientific assessment program is inspired by the well-recognized practices of the pharmaceutical industry and in line with the draft guidance of the U.S. FDA for Modified Risk Tobacco Product (MRTP) Applications. Our scientific studies resulted in more than 340 references in peer-reviewed articles in scientific journals and book chapters. All our clinical studies are registered on the public website www.ClinicalTrials.gov.
We encourage rigorous assessment of our scientific research, which is made transparently available for just that purpose. To date, there have been 73 independent studies and scientific reviews from universities and government research institutes in countries like Germany, Japan and the United Kingdom. In general, the conclusions from these studies and reviews are in line with PMI’s own data.
Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, outlines in his own vision statement that “under my leadership an enhanced and independent WHO will take a science-led and innovation-based approach that is results-oriented and responsive, maximizes inclusive partnerships, and ensures collective priority setting with all stakeholders.” https://www.who.int/dg/vision
One has to ask, why does the WHO not apply these same principles to tobacco control?
“We remain committed to having an open and transparent dialogue based on science,” said Dr. Gilchrist. “We cannot change the past, but we can change the future for the 1 billion people around the world who continue to smoke.”
Our smoke-free strategy complements efforts by the WHO to tackle smoking. Our aspiration is that, by 2025, at least 40 million people who would otherwise have smoked cigarettes will have switched to our smoke-free products (approximately 8 million people to date globally), reducing the number of smokers of PMI cigarette brands by a total 55 million by 2025. Our aspiration is to reduce smoking almost four times faster than the target set by WHO.
“We are shifting our business toward science-based better alternatives. We look forward to working with decision-makers in governments around the world and organizations such as the WHO to accelerate this transformation,” said Dr. Gilchrist. “Despite the WHO report, we remain steadfast in our commitment to unsmoke the world.”
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI’s smoke-free IQOS product portfolio includes heat-not-burn and nicotine-containing vapor products. As of June 30, 2019, PMI estimates that approximately 8.0 million adult smokers around the world have already stopped smoking and switched to PMI’s heat-not-burn product, available for sale in 48 markets in key cities or nationwide under the IQOS brand. For more information, please visit www.pmi.com and www.pmiscience.com.
Philip Morris International Media Office
T: +41 (0)58 242 4500
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF to Present at Barclays Global Consumer Staples Conference September 520.8.2019 23:15:00 EEST | Press release
Regulatory News: IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent, and nutrition & ingredients today announced that the Company’s management will speak at the Barclays Global Consumer Staples Conference in Boston, Massachusetts, on Thursday, Sept 5, 2019 at 2:15 PM ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), we’re using Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, we put science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products our world craves. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/ho
Novalis LifeSciences Launches its First Life Science Investment Fund with $85 Million20.8.2019 19:29:00 EEST | Press release
August 20th, 2019, Novalis LifeSciences, an investment and advisory firm for the Life Science industry, announced today that it has raised $85M in capital for its first fund - Novalis LifeSciences Investments I, L.P. Novalis LifeSciences is focused on highly innovative Life Science companies. On the occasion of closing the first fund, Marijn E. Dekkers, founder and chairman, said: “This first fund is a growth-oriented fund that will invest in 8-12 companies that are commercializing breakthrough technologies in various segments of the Life Science industry. This includes drug discovery, life science tools, genomics, synthetic biology, diagnostics, and agricultural biotechnology – all areas with huge unmet needs and exciting opportunities for investors”. About Novalis LifeSciences Novalis Lifesciences LLC, is a globally acting venture capital firm focused on breakthrough technologies in Life Science. Founded and managed by Dr. Marijn E. Dekkers, current chairman of Unilever and former ch
Bermuda Tech Week 2019 to Celebrate Innovation and Explore Opportunities for Growth20.8.2019 17:27:00 EEST | Press release
Registration is under way and filling fast for Bermuda Tech Week 2019 which will take place at the Hamilton Princess & Beach Club from October 14-18, 2019. The programme of insightful and engaging events will explore future opportunities and challenges presented by emerging technologies such as artificial intelligence, blockchain, digital assets, insurtech and virtual reality. It will showcase Bermuda’s ongoing success in creating a welcoming, stable and well-regulated environment where technology and start-up companies can thrive. “Bermuda has a long history of innovation so we understand and recognise the power of technology to positively impact both the economy and society,” said Bermuda Premier David Burt. “Over the past two years, we have built on our strength as a global leader in regulating the risks associated with the global insurance industry to develop a clear regulatory framework around managing the risks associated with Fintech. Our progressive approach has drawn accolades
Limelight Networks Expands Developer Toolkit With New API and Portal Enhancements20.8.2019 17:25:00 EEST | Press release
Limelight Networks, Inc. (Nasdaq: LLNW), a leading provider of edge cloud services, today announced it has expanded the management and configuration capabilities of its suite of services with new Application Programming Interfaces (APIs) and web portal offerings. With these new capabilities in addition to existing APIs and Software Development Kits, developers now have more power to manage and monitor services across Limelight’s edge cloud platform. According to an IDC surveyi, more than half the organizations surveyed have already adopted DevOps practices, with an additional 20 percent planning to do so in the next 12 months. To help organizations meet these demands, Limelight has introduced expanded API capabilities to provide developers with access to the full set of configuration options available across its content delivery services. Limelight’s new Configuration API enables developers to configure Limelight services and programmatically integrate them into their workflows. It exp
Andersen Global Enters Zimbabwe20.8.2019 16:30:00 EEST | Press release
Andersen Global announced it has signed a collaboration agreement with Chimwamurombe Legal Practice (Zenas) in Zimbabwe. Andersen Global has built a presence in over 14 African countries in just under two years. Zenas was founded in 2015 and now has a team of 11 professionals who provide legal services to individuals, organizations, institutions and corporations. With a specialty of serving small to medium enterprises, they offer solutions in mining and construction, commercial, debt recovery, property law, labor law, family law, tax, technology, telecommunications, media and intellectual property law, and criminal litigation. “When we started, we set out to be the most sought-after, trusted legal firm in Zimbabwe,” said Fungai Chimwamurombe, Zenas Office Managing Director. “These values line up very closely with those firms in the Andersen Global international organization. We are happy to join a team of professionals that is equally committed to treating clients like family and deliv
DXC Technology and Google Cloud Announce Global Partnership to Drive Innovation for Enterprises at Scale20.8.2019 16:00:00 EEST | Press release
DXC Technology (NYSE: DXC) today announced a strategic partnership with Google Cloud that will enable enterprise clients to modernize their mission-critical IT and integrate digital solutions on Google Cloud Platform. With the strategic partnership, DXC is also launching a Google Cloud Platform Center of Excellence (COE) and a Google Cloud Artificial Intelligence (AI) COE to provide clients in key industries with secure, scalable and agile cloud-based digital platforms that leverage advanced data analytics capabilities. The new collaboration will initially focus on joint solutions in industries such as insurance, oil and gas exploration, automotive, consumer products, retail, and banking and capital markets. Google Cloud now joins the DXC Partner Network as a strategic partner. “Our new Google Cloud partnership will benefit clients looking to go to the next level in their digital transformation,” said Edward Ho, executive vice president and general manager, Offerings, DXC. “Google Clou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom